Within the frame of a project on biologically active organometallic compounds twenty five triorganotin and organogermanium carboxylates of the type R 3 M0C(0)CH(0X)Ph (M = Sn, Ge; R = Me, Et, n-Bu; X = H, Me, C(0)Me, C(0)CF 3 , R 3 Ge), several diorganotin carboxylates R 2 Sn[0C(0)CH(0X)Ph] 2 (R = Et, n-Bu; X = Me, C(0)Me and {[R 2 Sn0C(0)CH(0X)Ph] 2 0} 2 (R = Et, n-Bu; X = Me, C(O)Me) and a new type of triorganogermanium carboxylates R 3 GeC^CCH 2 0C(0)CH(0X)R' (R = Me, Et, R' = Ph, Me, X = COCH 3 , COCF 3 ) have been synthesized and characterized by elemental analysis and structural methods (NMR, X-Ray, IR and Mössbauer).
Introduction.Organotin and organogermanium compounds are the subject of special interest as potential antitumor agents. The literature analysis shows that antitumor activity is mostly characteristic of the covalent compounds of germanium and tin, in which the fragments forming the intra-and intermolecular coordination bonds with germanium and tin atoms do exist.The organotin and organogermanium carboxylates are of this type. The new organogermanium and organotin derivatives of α-substituted phenylacetic acids are described in this paper. Because of the specific properties of organotin and organogermanium carboxylates we will first describe the germanium compounds, and, afterwards, the derivatives of tin.
ChemInform is a weekly Abstracting Service, delivering concise information at a glance that was extracted from about 100 leading journals. To access a ChemInform Abstract of an article which was published elsewhere, please select a “Full Text” option. The original article is trackable via the “References” option.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.